Business Context and Reporting Period
Company: MDxHealth SA
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: August 2022
Date of Filing: August 25, 2022
Headquarters: Herstal, Belgium
This filing serves to furnish a press release dated August 25, 2022, to U.S. investors. The document explicitly states that the attached press release is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Key Financial Metrics
The provided text contains no financial data. The filing is a procedural cover sheet for a press release and does not include revenue, profit, cash flow, margins, debt, or liquidity figures.
Material Changes
The filing text does not disclose specific material changes, financial comparisons, or operational updates. It only references the existence of an attached press release (Exhibit 99.1) without summarizing its content.
Guidance, Outlook, and Risks
No guidance, outlook, management commentary, risks, contingencies, or unusual items are detailed in the provided text. The document focuses solely on the regulatory mechanics of submitting the press release.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Press Release dated August 25, 2022) for the actual substance of the announcement.
- Verify if the press release contains material non-public information or significant operational updates not captured in this cover sheet.
- Confirm the company's status as a Foreign Private Issuer filing under Form 20-F.